Prevalence ofMITFp.E318K in Patients With Melanoma Independent of the Presence ofCDKN2ACausative Mutations-Reference-Cited by-同舟云学术

Prevalence ofMITFp.E318K in Patients With Melanoma Independent of the Presence ofCDKN2ACausative Mutations

Published:2016-04-01 Issue:4 Volume:152 Page:405
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Potrony Miriam¹,Puig-Butille Joan Anton²,Aguilera Paula³,Badenas Celia²,Tell-Marti Gemma³,Carrera Cristina³,Javier del Pozo Luis⁴,Conejo-Mir Julian⁵,Malvehy Josep³,Puig Susana³

Affiliation:

1. Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques d’August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain

2. Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain

3. Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques d’August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain

4. Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain

5. Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in melanoma: advances, pitfalls, and future perspectives;Frontiers in Molecular Biosciences;2024-06-28

2. MITF E318K: A rare homozygous case with multiple primary melanoma;Pigment Cell & Melanoma Research;2023-08-27

3. Melanoma risk prediction based on a polygenic risk score and clinical risk factors;Melanoma Research;2023-04-24

4. A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer;Acta Pharmacologica Sinica;2023-04-03

5. The MC1R r allele does not increase melanoma risk in MITF E318K carriers;British Journal of Dermatology;2023-03-05